• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
KE Xuan,HONG Hao.Research progress on nuclear G protein-coupled receptors[J].Journal Of Pharmaceutical Research,2021,40(4):247-250[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2514times   Download 2350次 QR Code for this article
Scan with your phone!
细胞核G蛋白偶联受体研究进展
柯璇,洪浩
Font:Larger+|Default|Smaller-
(中国药科大学药学院药理系,江苏 南京 210009)
摘要:
传统观念认为,G蛋白偶联受体通过自身在细胞表面的激活启动信号转导,从而介导细胞响应外界刺激。近年来研究发现了细胞核G蛋白偶联受体(nGPCR)的存在,有别于细胞质膜G蛋白偶联受体(mGPCR),细胞核G蛋白偶联受体具有独特的来源、功能、信号途径和作用模式。本文总结了目前对于细胞核G蛋白偶联受体的研究成果,以期为靶向G蛋白偶联受体的药物研发提供新的理念和思路。
关键词:  细胞核G蛋白偶联受体  核定位序列  核转位
DOI:10.13506/j.cnki.jpr.2021.04.010
基金项目:国家自然科学基金(No.81773714、81573413)
Publication Date:April 25, 2021
Research progress on nuclear G protein-coupled receptors
KE Xuan,HONG Hao
(Department of Pharmacology,School of Pharmacy,China Pharmaceutical University,Nanjing 210009,China)
Abstract:
In classical pharmacology, G protein-coupled receptors are characterized to initiate signal transduction through their activation on the cell surface as a cell response to extracellular stimuli.However,nuclear GPCRs (nGPCRs) have been found with particular features differed from plasma membrane GPCRs (mGPCRs) such as origins,functions,signaling pathways and patterns of action.This article summarized the current research progress on nGPCRs,with a purpose to providing new ideas and strategies for drug development targeting GPCRs.
Key words:  Nuclear GPCRs  Nuclear localization sequence (NLS)  Nuclear translocation
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.